Stay updated on Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FGBRw72waot_3YfL8BCAdwI5suJw.uncropped.jpg&w=3840&q=75)
Latest updates to the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.8%
- Check11 days agoChange DetectedDifference0.8%
- Check18 days agoChange DetectedDifference0.8%
- Check25 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check32 days agoChange DetectedDifference0.9%
- Check39 days agoChange DetectedDifference0.8%
Stay in the know with updates to Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page.